• Blood Samples  o Laboratory  documentation, including screening and confirmed concentrations (where applicable) of steroid Markers  (see TD LDOC [7]); For the Endocrine Module, the following additional information shall be provided for the tests selected by the APMU  and Expert  panel:  • Laboratory  documentation, including screening and confirmed concentrations (where applicable) of Markers  of the Endocrine Module (see TD LDOC [7]);          ABP Operating Guidelines  – Version 9.0 – July 2023  Page 83/91 9.0 References  [1] The World Anti -Doping Code International Standard for Results Management .